COngenital Multicenter trial of Pulmonic vAlve dysfunction Studying the SAPIEN 3 interventIONal THV - Post Approval Study
Sponsor: |
Edwards Lifesciences |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAT5807 |
U.S. Govt. ID: |
NCT02744677 |
Contact: |
Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu |
This study has been designed to treat patients with a pulmonary conduit or valve that has a largeamount of regurgitation or too narrow and needs to be replaced.
This study is closed
Investigator
Alejandro Torres, MD
Are you currently taking antibiotics? |
Yes |
No |